Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Patients with refractory or relapsed acute leukemia respond to weekly BMS-214662

Dec. 11, 2001

Procyon enters cancer technology option agreement

Dec. 11, 2001

FDA lifts hold on phase III trial of Aptosyn + Taxotere

Dec. 10, 2001

Tubulin polymerization inhibitor effective against refractory tumors in clinical trials

Dec. 10, 2001

PSC-833, an MDR modulator, examined in untreated AML patients of different age groups

Dec. 10, 2001

Sugen presents in vitro data on indolinone related to SU-5416 at Hematology meeting

Dec. 10, 2001

Thioredoxin-targeting class of antitumor agents synthesized at U.K. university

Dec. 7, 2001

SU-11654 inhibits receptor tyrosine kinases, including mutant forms of Kit

Dec. 7, 2001

Phosphoramidate prodrugs enabling enhanced intracellular delivery of drugs

Dec. 7, 2001

MediGene seeks marketing authorization for Leuprogel in Germany

Dec. 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...